Ubs Group Ag Immutep LTD Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Immutep LTD stock. As of the latest transaction made, Ubs Group Ag holds 23,019 shares of IMMP stock, worth $45,117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,019
Previous 1,849
1144.94%
Holding current value
$45,117
Previous $4,000
1125.0%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding IMMP
# of Institutions
32Shares Held
2MCall Options Held
259KPut Options Held
90.5K-
Black Rock Inc. New York, NY839KShares$1.64 Million0.0% of portfolio
-
Meridian Wealth Management, LLC394KShares$772,5340.04% of portfolio
-
Xy Capital LTD Central, K3165KShares$322,7230.17% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA116KShares$227,5930.0% of portfolio
-
Jane Street Group, LLC New York, NY80.5KShares$157,7580.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $170M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...